Accession Number: | 0001209191-14-054841 |
Date: | 2014-08-26 |
Issuer: | AGIOS PHARMACEUTICALS INC (AGIO) |
Original Submission Date: |
HIGGONS JOHN DUNCAN
C/O AGIOS PHARMACEUTICALS, INC.
38 SIDNEY STREET, 2ND FLOOR
CAMBRIDGE, MA 02139
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2014-08-26 | M | 5,000 | a | $0.30 | 181,090 | direct | ||
COMMON STOCK | 2014-08-26 | S | 5,000 | d | $45.05 | 176,090 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 0.3025 | 2014-08-26 | deemed execution date | M | 5,000 (d) | 2019-08-12 | common stock 5,000 | $0.30 | 303,767 | direct |
ID | footnote |
---|---|
f1 | this exercise was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person. |
f2 | this sale was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person. |
f3 | the price reported is the weighted average of the shares sold. the shares were sold at varying prices in the range of $45.00 to $45.23. the reporting person undertakes, upon request by the staff of the securities and exchange commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
f4 | this option was granted on august 13, 2009. the shares underlying this option vest as to 25% of the shares on may 18, 2010, with the remaining 75% vesting in 36 equal monthly installments thereafter. |